EyePoint Pharmaceuticals Inc. buy JPMorgan Chase & Co.
Start price
13.08.24
/
50%
€7.68
Target price
13.08.25
€26.50
Performance (%)
18.65%
End price
14.08.25
€9.11
Summary
This prediction ended on 14.08.25 with a price of €9.11. The prediction had a final performance of 18.65%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -15.872% | -15.872% | 56.223% |
| iShares Core DAX® | -1.020% | 0.271% | 13.941% |
| iShares Nasdaq 100 | -3.122% | -1.929% | 1.920% |
| iShares Nikkei 225® | 0.649% | 6.582% | 21.176% |
| iShares S&P 500 | -0.142% | -0.295% | 1.363% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its price target lowered by analysts at JPMorgan Chase & Co. from $32.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.46
04.06.24
04.06.24
€29.43
04.06.25
04.06.25
-15.94%
05.06.25
05.06.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.60
22.01.24
22.01.24
€32.12
22.01.25
22.01.25
-61.75%
23.01.25
23.01.25